Chemotherapy for Leukemia Novel Drugs and Treatment /

This book focuses on the latest progress in chemotherapy for leukemia and related diseases, including still-ongoing but promising studies. The effectiveness of treatment for chronic myeloid leukemia and acute promyelocytic leukemia has been dramatically improved in recent years. This improvement has...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Ueda, Takanori (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2017.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • 1 An Overview
  • Part I Bcr-Abl Tyrosine Kinase Inhibitors (TKIs)
  • 2 Imatinib: Basic Results
  • 3 Imatinib: Clinical Pharmacology and Therapeutic Results
  • 4 Dasatinib, Nilotinib, Bosutinib, Ponatinib, and Other TKIs
  • Part II New Antibodies for Leukemia
  • 5 Rituximab and Alemtuzumab for Chronic Lymphocytic Leukemia: Basic Results
  • 6 Rituximab and Alemtuzumab for Chronic Lymphocytic Leukemia: Clinical Pharmacology and Therapeutic Results
  • 7 Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia: Clinical Pharmacology and Therapeutic Results
  • 8 Blinatumomab for Acute Lymphoblastic Leukemia: Clinical Pharmacology and Therapeutic Results
  • 9 Mogamulizumab in Adult T-cell Leukemia/Lymphoma
  • Part III Signaling inhibitors
  • 10. FLT3 inhibitors
  • Part IV Differentiating Agents
  • 11 Retinoic Acid, All-Trans Retinoic Acid (ATRA) and Tamibarotene
  • 12 The Molecular Basis of Arsenic Trioxide Treatment for Acute Promyelocytic Leukemia (APL)
  • 13 Arsenic Trioxide: Clinical Pharmacology and Therapeutic Results
  • Part V New Chemotherapeutic Agents Including Antimetabolite
  • 14 Nelarabine
  • 15 Forodesine
  • 16 Clofarabine: Structure, Mechanism of Action, and Clinical Pharmacology
  • 17 Clinical Use of Clofarabine for Adults and Children with Leukemia
  • 18 Re-Emerging Antimetabolites with Novel Mechanism of Action with Respect to Epigenetic Regulation: Basic Aspects
  • 19 Epigenetic Regulator, Re-Emerging Antimetabolites with Novel Mechanism of Action (Azacitidine and Decitabine): Clinical Pharmacology and Therapeutic Results
  • Part VI Therapy Targeting Leukemic Stem Cells
  • 20 Therapies Targeting Leukemic Stem Cells.